Information Provided By:
Fly News Breaks for August 10, 2016
IPXL
Aug 10, 2016 | 08:07 EDT
After the company reported a "disappointing" top and bottom-line miss, Leerink analyst Jason Gerberry lowered his price target for Impax to $24 from $33 on the company's limited revenue upside and U.S. generics outlook. The analyst reiterates a Market Perform rating on the shares.
News For IPXL From the Last 2 Days
There are no results for your query IPXL